196 related articles for article (PubMed ID: 34148069)
41. Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer.
Chen X; Yang Z; Feng J; Duan T; Pan T; Yan L; Jin T; Xiang Y; Zhang M; Chen P; Wang W; Zhang R; Chen B; Zhao L; Xie T; Sui X
Cancer Med; 2021 Jan; 10(1):317-324. PubMed ID: 33174323
[TBL] [Abstract][Full Text] [Related]
42. Ring finger 220 promotes the stemness and progression of colon cancer cells via Ubiquitin specific peptidase 22-BMI1 axis.
Yan J; Tan M; Yu L; Jin X; Li Y
Bioengineered; 2021 Dec; 12(2):12060-12069. PubMed ID: 34753387
[TBL] [Abstract][Full Text] [Related]
43. KMT2A histone methyltransferase contributes to colorectal cancer development by promoting cathepsin Z transcriptional activation.
Fang Y; Zhang D; Hu T; Zhao H; Zhao X; Lou Z; He Y; Qin W; Xia J; Zhang X; Ye LC
Cancer Med; 2019 Jul; 8(7):3544-3552. PubMed ID: 31090199
[TBL] [Abstract][Full Text] [Related]
44. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
[TBL] [Abstract][Full Text] [Related]
45. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1.
Zhang L; Dong X; Yan B; Yu W; Shan L
Cell Death Dis; 2020 Jul; 11(7):542. PubMed ID: 32681092
[TBL] [Abstract][Full Text] [Related]
46. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
[TBL] [Abstract][Full Text] [Related]
47. MORC4 plays a tumor-promoting role in colorectal cancer via regulating PCGF1/CDKN1A axis in vitro and in vivo.
Liang Y; Wu D; Qu Q; Li Z; Yin H
Cancer Gene Ther; 2023 Jul; 30(7):985-996. PubMed ID: 36932196
[TBL] [Abstract][Full Text] [Related]
48. Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation.
Lourenço FC; Munro J; Brown J; Cordero J; Stefanatos R; Strathdee K; Orange C; Feller SM; Sansom OJ; Vidal M; Murray GI; Olson MF
Gut; 2014 Mar; 63(3):480-93. PubMed ID: 23585469
[TBL] [Abstract][Full Text] [Related]
49. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
[TBL] [Abstract][Full Text] [Related]
50. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
[TBL] [Abstract][Full Text] [Related]
51. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.
Kodach LL; Jacobs RJ; Heijmans J; van Noesel CJ; Langers AM; Verspaget HW; Hommes DW; Offerhaus GJ; van den Brink GR; Hardwick JC
Carcinogenesis; 2010 Sep; 31(9):1567-75. PubMed ID: 20631058
[TBL] [Abstract][Full Text] [Related]
52. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.
Jin L; Hanigan CL; Wu Y; Wang W; Park BH; Woster PM; Casero RA
Biochem J; 2013 Jan; 449(2):459-68. PubMed ID: 23072722
[TBL] [Abstract][Full Text] [Related]
53. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
[TBL] [Abstract][Full Text] [Related]
54. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
[TBL] [Abstract][Full Text] [Related]
55. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
56. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.
Yu L; Ye F; Li YY; Zhan YZ; Liu Y; Yan HM; Fang Y; Xie YW; Zhang FJ; Chen LH; Ding Y; Chen KL
Carcinogenesis; 2020 Jul; 41(5):678-688. PubMed ID: 31306481
[TBL] [Abstract][Full Text] [Related]
57. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
[TBL] [Abstract][Full Text] [Related]
58. KDM5D inhibits the transcriptional activation of FKBP4 by suppressing the expression of E2F1 in colorectal cancer in males.
Liu M; Gao N
Biochem Pharmacol; 2021 Dec; 194():114814. PubMed ID: 34688635
[TBL] [Abstract][Full Text] [Related]
59. Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.
Ciesielski O; Biesiekierska M; Balcerczyk A
Molecules; 2020 May; 25(10):. PubMed ID: 32429384
[TBL] [Abstract][Full Text] [Related]
60. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
